The global Narcolepsy Therapeutics Market is anticipated to witness an exponential growth in the forecast period. Narcolepsy is a prolonged neurological disorder related to excessive daytime sleepiness (EDS), cataplexy, hypnagogic hallucinations, sleep paralysis, and fragmented night sleep.
Factors such as rising incidence across the globe, changing lifestyle, increasing research activities, increasing awareness about the disease and the available treatment options, and increasing healthcare expenditure are likely to drive the narcolepsy therapeutics industry in the forthcoming period. On the other hand, high cost and lack of awareness are anticipated to hinder the market growth in the future.
Download Sample Report @ https://www.millioninsights.com/industry-reports/narcolepsy-therapeutics-market/request-sample
Narcolepsy Therapeutics market is segmented by type, product type, and geography. The market is segmented by type as secondary narcolepsy, narcolepsy with cataplexy, and narcolepsy without cataplexy. The “narcolepsy without cataplexy” segment accounts for a prominent share in the market. It is likely to witness substantial growth in the years to come. The factors that could be attributed to the growth of the market include growing consciousness about excessive daytime sleepiness (EDS) through numerous media.
Based on product type, the market is segmented as sodium oxybate, central nervous system stimulants, tricyclic antidepressants, selective serotonin reuptake inhibitor, and others. The “sodium oxybate” segment accounts for a prominent share in the market. It is likely to witness exuberant growth in the years to come. The factors that could be attributed to the growth of the market are presence of favorable reimbursement rules, and rising consciousness levels relating to the disease.
Europe is a leading region in the market. It is likely to maintain its dominance in the forecast period owing to factors such as governments’ initiatives with respect to research and development and rising awareness among the population. Europe is followed by the Asia-Pacific region owing to lifestyle changes, rising standard of living, focus on healthcare expenses.
Key players operating in the narcolepsy therapeutics market include Jazz Pharmaceuticals Plc, Teva Pharmaceutical Industries Ltd., Ligand Pharmaceuticals, Inc., Gray mark Healthcare, Inc., Arena Pharmaceuticals, Inc., Shire Plc, and Others. The leading companies are involved in partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.
Market Segment:
Narcolepsy Therapeutics Type Outlook (Revenue, USD Million, 2014 - 2025)
- Narcolepsy with Cataplexy
- Narcolepsy Without Cataplexy
- Secondary Narcolepsy
Narcolepsy Therapeutics Product Outlook (Revenue, USD Million, 2014 - 2025)
- Central Nervous System Stimulants
- Sodium Oxybate
- Selective Serotonin Reuptake Inhibitor
- Tricyclic Antidepressants
- Others
Narcolepsy Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Middle East & Africa
- South Africa
Continued…
New York, NY 19 Feb 2021: The Global Narcolepsy Therapeutics Market is anticipated to reach over USD 3263.65 Million by 2025 according to a new research published by Polaris Market Research.
Narcolepsy is a therapeutic disorder which is categorized by prodigious daytime sleepiness as well as sudden attacks of sleep.
Some of the most common indications of narcolepsy are daytime sleepiness, hallucinations, fragmented sleep & insomnia, and sleep paralysis.
Moreover, according to the Australian Institute of Health and Welfare, around 63% of the Australian individuals who are aged over 18 years were estimated to be obese or overweight.
However, low per capita healthcare spending and lack of awareness majorly in middle income and lower-income economies is estimated to hinder the global narcolepsy therapeutics market during the forecast period.
In 2017, Sodium oxybate was estimated to domkiat5e the market segment.
Esticast Research & Consulting adds a new research report titled, ‘Global Narcolepsy Therapeutics Market’ to its huge database of research reports.
It also covers projections by making use of a suitable set of estimates and methodologies.About Narcolepsy Therapeutics Market:Narcolepsy Therapeutics Market is expected to grow with a CAGR of 6.1% during the forecast period of 2018 to 2025.
Narcolepsy is neurological disorder that disrupts the sleep-wake cycle in humans, leading to excessive daytime sleepiness and loss of muscle strength.
Such notable percentage figure is anticipated to provide lucrative opportunities to the market players during the upcoming years, in correlation to the technological advancements occurring in the medical diagnosis.For Better Understanding, Try Sample PDF Brochure of Report (including full TOC, Tables and Figures) @ https://www.esticastresearch.com/report/narcolepsy-therapeutics-market/#request-for-sampleThe Global Narcolepsy Therapeutics Market report offers an in-depth analysis of the global market taking into account segmentation, market dynamics, competitive landscape, geographical analysis, and many other key aspects.
The domain experts who have planned the report have thoroughly studied the global Narcolepsy Therapeutics market and have catered reliable and accurate data.They recognize the needs of the industry and the clients, which makes it simple for them to focus on the aspects, which the clients have been looking for.
The research report comprises of an analysis of an evaluation of the existing and upcoming trends that companies can invest in.
